The Diabetic Ketoacidosis Treatment Market is growing due to rising diabetes prevalence, improved diagnostics, and innovative treatment options like fast-acting insulin and remote monitoring.

Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...